X0306 4 2022-09-12 false 0001412408 Phreesia, Inc. PHR 0001776729 Linetsky David C/O PHREESIA, INC. 1521 CONCORD PIKE, SUITE 301 PMB 221 WILMINGTON DE 19803 false true false false SVP, Life Sciences Common Stock 2022-09-12 4 A false 1589.00 A 226074.00 D Common Stock 2022-09-12 4 F false 626.00 29.19 D 225448.00 D Common Stock 5683.00 I By spouse Stock Option (Right to buy) 4.71 2028-10-24 Common Stock 285.00 285.00 I By spouse Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the first half of the fiscal year ending January 31, 2023 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted are based on a per share value of $29.19, the closing price of the Issuer's common stock on September 12, 2022. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of fully vested RSUs granted on September 12, 2022 and does not represent a sale by the Reporting Person. 228 of the shares subject to this option are vested as of the date hereof, and the remaining shares will vest and become exercisable in two equal installments on September 25, 2022 and October 25, 2022. /s/ Allison Hoffman by Power of Attorney for David Linetsky 2022-09-14